Lucy Lu

Dr. Lu has over 20 years of extensive experience in the biotechnology and healthcare industries as an investment banker, financial analyst and executive of listed biopharmaceutical companies in the United States. She brings additional skills to Inventiva’s board in the areas of finance and clinical development as well as American market experience.

In addition to her functions at Inventiva, Dr. Lu has served as President and Chief Executive Officer of Avenue Therapeutics, Inc., a public biotechnology company, since its inception in 2015. Previously, she was Executive Vice President and Chief Financial Officer of Fortress Biotech, Inc. from 2012 to 2017. Dr. Lu worked as Senior Biotechnology Analyst for Citigroup Inc. from 2007 until 2012.

Dr. Lu holds a MD from New York University School of Medicine and a MBA from Leonard N. Stern School of Business at New York University. She also received a bachelor’s degree from the University of Tennessee’s College of Arts and Sciences.